Related Experiment Video
Updated: Jan 2, 2026

11:55
Membrane Transport Processes Analyzed by a Highly Parallel Nanopore Chip System at Single Protein Resolution
Published on: August 16, 2016
12.0K
Destructing the Plasma Membrane with Activatable Vesicular DNA Nanopores
Liang Chen1, Siping Liang2, Yu Chen2
1School of Pharmaceutical Sciences , Sun Yat-sen University , Guangzhou 510006 , P. R. China.
ACS Applied Materials & Interfaces
|December 10, 2019
Summary
Researchers developed novel DNA nanopores called FLIPs that can be controllably inserted into lipid membranes. These FLIPs induce cancer cell death and inhibit tumor growth, offering a promising new avenue for cancer nanotherapy.
Area of Science:
- Biochemistry
- Nanotechnology
- Oncology
Background:
- Pore-forming proteins are crucial in biological processes and have therapeutic potential in cancer treatment.
- Existing DNA nanopores struggle with efficient incorporation into lipid bilayers.
Purpose of the Study:
- To develop a novel DNA nanopore system for controlled lipid membrane perforation.
- To investigate the therapeutic efficacy of these novel DNA nanopores in cancer models.
Main Methods:
- Design and synthesis of fusogenic liposome-incorporated transmembrane DNA nanopores (FLIPs).
- Utilizing low pH conditions for steric deshielding and controlled membrane perforation.
- Assessing FLIPs' effect on plasma membrane depolarization and pyroptosis-like cell death.
- Evaluating FLIPs' anti-tumor efficacy in murine tumor models.
Main Results:
- FLIPs demonstrate controlled perforation of lipid bilayers.
- FLIPs induce plasma membrane depolarization, leading to pyroptosis-like cell death.
- FLIPs effectively inhibit tumor growth in preclinical cancer models.
Conclusions:
- Vesicular DNA nanopores (FLIPs) offer a controllable method for lipid membrane perforation.
- FLIPs show significant potential as a novel therapeutic strategy for cancer nanotherapy.
Related Concept Videos
Fusion of Secretory Vesicles with the Plasma Membrane
16.4K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.4K
Pinching-off of Coated Vesicles
3.9K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.9K
DNA Bacteriophages
688
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
688

